Efficacy, tolerability, and safety of 1.5L-lactulose as bowel preparation for patients with inflammatory bowel disease: a randomized, single-blinded trial
Internal and Emergency Medicine · 2026-08 · 21 (5) · 1709-1719
DOI: 10.1007/s11739-026-04358-2 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Internal and Emergency Medicine, online erschienen am 17.04.2026. Verfasst von Ye Fang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China. Hauptthemen laut MEDLINE: Cathartics, Inflammatory Bowel Diseases, Lactulose. Die Arbeit nennt 37 Literaturangaben. Gefördert von: Natural Science Foundation of Zhejiang Province, Zhejiang Traditional Chinese Medicine Administration, Science and Technology Plan Project of Wenzhou Municipality.
Abstract (Originalsprache)
BACKGROUND: Lactulose is a novel laxative with low volume and excellent tolerability. It used as a bowel preparation for colonoscopy has so far limited application. We compared the effectiveness, tolerability, and safety of lactulose with those of polyethylene glycol (PEG) in bowel preparation of patients with inflammatory bowel disease (IBD). METHODS: We enrolled 140 patients with clinically inactive IBD who required colonoscopy and randomly divided them into the 3L-PEG group or the 1.5L-Lactulose group. Bowel cleansing was assessed using the Boston Bowel Preparation Scale. The tolerability and satisfaction of the bowel preparation methods were evaluated using self-administered questionnaires. Safety was assessed by monitoring electrolytes, and liver and kidney functions in partial patients. RESULTS: The successful bowel preparation rate was higher in the Lactulose group than in the PEG group (92.9% versus 81.4%, P = 0.0434). According to the multivariable analyses, the male sex was an independent risk factor of efficacy. The responses to self-administered questionnaires revealed that the Lactulose group experienced significantly better taste and had a higher willingness to repeat the same regimen than the PEG group (P 0.05). The multivariable analyses revealed age was an independent factor of adverse events. CONCLUSIONS: 1.5L-Lactulose had a higher bowel cleansing success rate and higher tolerability with acceptable safety than 3L-PEG. Therefore, 1.5L-Lactulose may be a potential option for bowel preparation in inactive IBD patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
- Department of Hepatology, Ningbo No.2 Hospital, Ningbo, China.
- Department of Gastroenterology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China. wzjiangyi@yeah.net.
- Department of Gastroenterology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China. wmuldp@163.com.
Förderung
- Natural Science Foundation of Zhejiang Province
- Zhejiang Traditional Chinese Medicine Administration
- Science and Technology Plan Project of Wenzhou Municipality
- Lin He's New Medicine and Clinical Translation Academician Workstation Research Fund
Zitieren
APA
Fang, Y., Fang, L., Hu, D., Shao, X., Ma, G., Xu, Y., Jiang, Y., & Lin, D. (2026). Efficacy, tolerability, and safety of 1.5L-lactulose as bowel preparation for patients with inflammatory bowel disease: a randomized, single-blinded trial. Internal and Emergency Medicine, 21(5), 1709-1719. https://doi.org/10.1007/s11739-026-04358-2
Vancouver
Fang Y, Fang L, Hu D, Shao X, Ma G, Xu Y, et al. Efficacy, tolerability, and safety of 1.5L-lactulose as bowel preparation for patients with inflammatory bowel disease: a randomized, single-blinded trial. Internal and Emergency Medicine. 2026;21(5):1709-1719. doi:10.1007/s11739-026-04358-2
BibTeX
@article{Fang2026,
author = {Fang, Ye and Fang, Luyan and Hu, Dingyuan and Shao, Xiaoxiao and Ma, Guolong and Xu, Yuan and Jiang, Yi and Lin, Daopo},
title = {Efficacy, tolerability, and safety of 1.5L-lactulose as bowel preparation for patients with inflammatory bowel disease: a randomized, single-blinded trial},
journal = {Internal and Emergency Medicine},
year = {2026},
volume = {21},
number = {5},
pages = {1709--1719},
doi = {10.1007/s11739-026-04358-2}
}
EUVIMED